Open Abdomen Study Comparing ABThera™ Open Abdomen Negative Pressure Therapy System and Barker's Vacuum Packing Technique
Launched by KCI USA, INC · Nov 18, 2009
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
This study is being done to gather data that will be used to compare two different TAC (Temporary Abdominal Closure) methods. The two TAC methods being compared are the Barker's vacuum packing technique or BVPT and the Open Abdomen Negative Pressure Therapy System (ABThera) developed by the sponsor of this research (KCI, San Antonio, TX). The BVPT is made up of supplies that are stocked in most surgery rooms. The ABThera dressing is available commercially. Neither method will be supplied to the doctor (Principal Investigator), so that in no way would the subject's standard of care be differ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subjects 18-75 years of age
- 2. OA Subjects treated with only one of the following TACs at initial placement (defined as the time of the first application of a TAC method):
- • 1. ABThera
- • 2. BVPT
- Exclusion Criteria:
- • 1. Pregnant females
- • 2. Active, uncontrolled hemorrhage at the time of TAC placement
- • 3. Diagnosis of pre-existing bleeding disorder
- • 4. Known allergy or hypersensitivity to polyvinyl, polyurethane, acrylic, or acrylic adhesive
- • 5. Subjects with fistulas
- • 6. Subjects who have been enrolled in this study previously
- • 7. Documented history of Child-Pugh Turcot Liver Dysfunction - Class C (10-15 points) at the time of enrollment
- • 8. Subjects with body mass index (BMI) \> 40 as estimated at the time of Emergency Department (ED) or OR admission
- • 9. Known New York Heart Association Functional Classification - Class IV at the time of enrollment
About Kci Usa, Inc
KCI USA, Inc. is a leading medical technology company specializing in advanced wound care and therapeutic solutions. With a commitment to innovation and quality, KCI develops and manufactures products that enhance patient outcomes in various clinical settings. The company focuses on research and development to drive clinical advancements, providing healthcare professionals with effective tools for managing complex wounds and improving overall patient care. KCI's dedication to clinical excellence and patient safety positions it as a trusted partner in the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Oklahoma City, Oklahoma, United States
Portland, Oregon, United States
Mobile, Alabama, United States
Los Angeles, California, United States
Orlando, Florida, United States
Chicago, Illinois, United States
New Orleans, Louisiana, United States
Baltimore, Maryland, United States
Philadelphia, Pennsylvania, United States
Memphis, Tennessee, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials